Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jung Feng

Showing results (111-120 of 125) with videos related to

Pageof 13
Sort By:
The Oncologist|September 2, 2025
Real-world evaluation of CDK4/6 inhibitors in hormone receptor-positive metastatic breast cancer: Prognostic effect of proton pump inhibitor useBo-Fang Chen, Jiun-I Lai, Yi-Fang Tsai, et al.
Frontiers in Oncology|September 1, 2023
Prevalence of <i>PIK3CA</i> mutations in Taiwanese patients with breast cancer: a retrospective next-generation sequencing database analysisTa-Chung Chao, Yi-Fang Tsai, Chun-Yu Liu, et al.
Breast Cancer (Tokyo, Japan)|December 9, 2023
Prevalent landscape of tumor genomic alterations of luminal B1 breast cancers using a comprehensive genomic profiling assay in TaiwanBo-Fang Chen, Yi-Fang Tsai, Pei-Ju Lien, et al.
Journal of the Neurological Sciences|April 9, 2018
Motor and non-motor features of Parkinson's disease in LRRK2 G2019S carriers versus matched controlsSteven A Gunzler, David E Riley, Shu G Chen, et al.
Annals of Surgical Oncology|February 28, 2022
Prevalence of Tumor Genomic Alterations in Homologous Recombination Repair Genes Among Taiwanese Breast CancersChi-Cheng Huang, Yi-Fang Tsai, Chun-Yu Liu, et al.
Translational Oncology|September 15, 2023
Correlation of an immune-related 8-gene panel with pathologic response to neoadjuvant chemotherapy in patients with primary breast cancersLing-Ming Tseng, Chi-Cheng Huang, Yi-Fang Tsai, et al.
Aesthetic Plastic Surgery|March 6, 2025
Mastectomy Alone or with Immediate Breast Reconstruction: Trend, Precipitating Factors, Patients Reported Outcome, and Oncologic Safety Analysis with and without Propensity Score Matching from 3759 Mastectomy PatientsYi-Yuan Lee, Hung-Wen Lai, Antonio Muñoz Guevara, et al.
BMC Cancer|March 3, 2026
Circulating tumor cells (CTCs) enumeration and machine-learning based diagnostic biomarkers for breast cancer detectionChun-Yu Liu, Yu-Hsiang Lin, Yi-Fang Tsai, et al.
Journal of the Chinese Medical Association : JCMA|September 25, 2021
Clinical outcomes and metastatic behavior between de novo versus recurrent HER2-positive metastatic breast cancer: A 17-year single-institution cohort study at Taipei Veterans General HospitalHan-Fang Cheng, Yi-Fang Tsai, Chi-Cheng Huang, et al.
Breast Cancer Research : BCR|December 30, 2025
Circulating T-cell receptor repertoire and clinicopathological correlations in breast cancer patients: immune repertoire analysis from the VGH-TAYLOR studyLing-Ming Tseng, Chi-Cheng Huang, Ji-Lin Chen, et al.
Pageof 13

Showing results (111-120 of 125) with videos related to

Sort By:
Pageof 13
The Oncologist|September 2, 2025
Real-world evaluation of CDK4/6 inhibitors in hormone receptor-positive metastatic breast cancer: Prognostic effect of proton pump inhibitor useBo-Fang Chen, Jiun-I Lai, Yi-Fang Tsai, et al.
Frontiers in Oncology|September 1, 2023
Prevalence of <i>PIK3CA</i> mutations in Taiwanese patients with breast cancer: a retrospective next-generation sequencing database analysisTa-Chung Chao, Yi-Fang Tsai, Chun-Yu Liu, et al.
Breast Cancer (Tokyo, Japan)|December 9, 2023
Prevalent landscape of tumor genomic alterations of luminal B1 breast cancers using a comprehensive genomic profiling assay in TaiwanBo-Fang Chen, Yi-Fang Tsai, Pei-Ju Lien, et al.
Journal of the Neurological Sciences|April 9, 2018
Motor and non-motor features of Parkinson's disease in LRRK2 G2019S carriers versus matched controlsSteven A Gunzler, David E Riley, Shu G Chen, et al.
Annals of Surgical Oncology|February 28, 2022
Prevalence of Tumor Genomic Alterations in Homologous Recombination Repair Genes Among Taiwanese Breast CancersChi-Cheng Huang, Yi-Fang Tsai, Chun-Yu Liu, et al.
Translational Oncology|September 15, 2023
Correlation of an immune-related 8-gene panel with pathologic response to neoadjuvant chemotherapy in patients with primary breast cancersLing-Ming Tseng, Chi-Cheng Huang, Yi-Fang Tsai, et al.
Aesthetic Plastic Surgery|March 6, 2025
Mastectomy Alone or with Immediate Breast Reconstruction: Trend, Precipitating Factors, Patients Reported Outcome, and Oncologic Safety Analysis with and without Propensity Score Matching from 3759 Mastectomy PatientsYi-Yuan Lee, Hung-Wen Lai, Antonio Muñoz Guevara, et al.
BMC Cancer|March 3, 2026
Circulating tumor cells (CTCs) enumeration and machine-learning based diagnostic biomarkers for breast cancer detectionChun-Yu Liu, Yu-Hsiang Lin, Yi-Fang Tsai, et al.
Journal of the Chinese Medical Association : JCMA|September 25, 2021
Clinical outcomes and metastatic behavior between de novo versus recurrent HER2-positive metastatic breast cancer: A 17-year single-institution cohort study at Taipei Veterans General HospitalHan-Fang Cheng, Yi-Fang Tsai, Chi-Cheng Huang, et al.
Breast Cancer Research : BCR|December 30, 2025
Circulating T-cell receptor repertoire and clinicopathological correlations in breast cancer patients: immune repertoire analysis from the VGH-TAYLOR studyLing-Ming Tseng, Chi-Cheng Huang, Ji-Lin Chen, et al.
Pageof 13